INTRODUCTION
The initial embryonic vasculature is established through a process know as vasculogenesis . The migration of angioblasts during vasculogenesis is driven by expression of vascular endothelial cell growth factor (VEGF) in the embryo and expression of the VEGF receptor FLK-1 (also know as VEGFR2) in the angioblasts (Flamme et al., 1995a; Dumont et al., 1995; Shalaby et al., 1995) . The joining of progenitor cells to form vessel walls occurs during differentiation of angioblasts into vascular endothelial cells. The initial capillary network is extensively remodeled to form a vascular tree with large and small arteries and veins and interconnecting fine capillary networks. The processes regulating vascular remodeling and growth have been collectively termed angiogenesis and are also regulated by expression of VEGF in the surrounding tissue (reviewed in Risau, 1997) . In humans, five VEGF-A isotypes are produced from alternatively spliced transcripts of a single gene, which result in secreted proteins of 121, 145, 165, 189 , and 206 amino acids (Poltorak et al., 1997) . Mice have four VEGF-A isotypes, three of which are produced from similar splice variants that encode the human 121, 165, and 189 proteins, but the mouse cDNA has a unique splice variant that encodes a protein of 115 amino acids (Shima et al., 1996; Sugihara et al., 1998) . In both species the VEGF-A 164 is by far the most abundant and is the most potent mitogen for vascular endothelial cells. Mice that are homozygous for a null mutation in the VEGF-A gene die around 8.5 to 9.5 days after fertilization due to severe defects in vascularization (Carmeliet et al., 1996) . The absence of vascular cells in the anterior end of VEGF-A null embryos, the scant population of endothelial cells, and the lack of blood vessel organization in the posterior end suggest that VEGF-A is essential for endothelial cell survival, proliferation, and vascular organization. Two highaffinity VEGF-A receptors, VEGFR1 (also known as Flt-1) and VEGFR2 (also known as Flk-1), are expressed by angioblasts and vascular endothelial cells (Millauer et al., 1993; Finnerty et al., 1993) . Targeted mutations in mice have demonstrated that both receptors are essential for unique steps in vascular development (Shalaby et al., 1995; Fong et al., 1999) .
To investigate the role of VEGF-A in vascular development of the eye, we created transgenic mice that express human VEGF-A 165 in the lens. A schematic drawing of the vasculature in the normal embryonic eye is shown in Fig.  1A . The embryonic lens vasculature, known as the tunica vasculosa lentis (TVL), is simple and provides a unique in vivo model system to study the effects of VEGF-A on migration, proliferation, and differentiation of angioblasts during early eye development. The lens vasculature in mice begins to degenerate after birth and is completely regressed at weaning (3 weeks) (Jack, 1972) . We analyzed prenatal and postnatal mice to determine if VEGF-A could function as an endothelial cell survival factor and prevent vascular regression around the lens. The transgenic mice show dramatic changes in the TVL architecture, but interestingly, there was no vascularization of the lens interior. The most dramatic change was an enhanced migration and proliferation of angioblasts around the embryonic lens. The angioblasts accumulated into a dense vascular bed which did not organize into well-defined blood vessels. This early phenotype provides in vivo evidence that VEGF-A can promote vasculogenesis by stimulating proliferation and migration of angioblasts. The phenotype in postnatal mice suggests that while VEGF-A can stimulate endothelial cell survival, proliferation, and angiogenic remodeling, it is insufficient to stimulate blood vessel maturation. The developmental changes that occur in the lens vascular bed are consistent with the hypothesis that blood vessel maturation requires an appropriate balance of VEGF-A with other vascular maturation signals.
MATERIALS AND METHODS

Generation and Screening of Transgenic Mice
Transgenic mice were generated using an ␣A-crystallin-VEGF-A minigene (Fig. 1B) . To generate this minigene a 596-bp BamHI fragment containing the human VEGF-A cDNA (obtained from Dr. Bill LaRochelle, NIH) encoding the 165-amino-acid form of VEGF-A was inserted into a BamHI site downstream of a minimal 360-bp ␣A-crystallin promoter (Reneker et al., 1995) . To generate transgenic mice the 1.8-kb crystallin-VEGF-A minigene (Fig. 1B) was released from the plasmid vector by NotI digestion followed by agarose gel electrophoresis. The fragment was purified using a quick spin gel extraction kit (Qiagen) and eluted in 10 mM Tris-HCl pH 7.4, 0.1 mM EDTA. The DNA (diluted to 2 ng/l) was microinjected into pronuclei of one-cell stage FVB/N embryos (Taketo et al., 1991; Hogan et al., 1996) . Injected embryos were implanted into pseudopregnant ICR females for normal gestation and delivery. To identify transgenic mice, genomic DNA samples were isolated from tail biopsies and were analyzed using polymerase chain reaction (PCR). Founder mice were mated to FVB/N mice to establish transgenic families.
PCR Analyses
PCR amplifications were carried out using a sense primer (Pr-4, GCATTCCAGCTGCTGACGGT) which anneals to sequences Ϫ165 to Ϫ146 in the ␣A-crystallin promoter and an antisense primer (SV40-B, GTCCTTGGGGTCTTCTACCTTTCTC) which anneals to the SV40 sequences (Fig. 1B) . PCRs (50 l) consisted of 5-l DNA samples, 10 mM Tris-HCl (pH 8.3), 50 mM KCl, 1.5 mM MgCl 2 , 0.1% gelatin, 25 M each dNTP, 4 M each primer, and 2.5 units of Taq DNA polymerase (Perkin-Elmer Cetus). Reactions were denatured at 94°C for 2 min, then subjected to 30 cycles of 94°C for 30 s, 58°C for 30 s, and 72°C for 1 min. A 15-l aliquot from each reaction was analyzed for the presence of a 1.1-kb amplification product by electrophoresis in a 1% agarose gel.
In Situ Hybridizations
In situ hybridizations were carried out using 35 S-labeled riboprobes as described previously (Robinson et al., 1995) . A transgenespecific riboprobe was generated by in vitro transcription of a plasmid containing the SV40 sequences indicated in Fig. 1B 
Tissue Preparation and Routine Histology
Eyes were enucleated and fixed in 10% formalin for 24 h prior to dehydration and embedding in paraffin. All histological procedures were carried out on 5-m paraffin sections which had been deparaffinized in xylene and rehydrated in an ethanol series. Sections were stained with hematoxylin and eosin for routine histology.
Cell Proliferation Assay
Incorporation of 5Ј-bromo-2Ј-deoxyuridine (BrdU) was used to assess cell proliferation as described previously (Fromm et al., 1994) . BrdU [100 g BrdU/g body weight (Sigma Chemicals) and 6 g 5Ј-fluoro-2Ј-deoxyuridine/g body weight (Sigma Chemicals) in phosphate-buffered saline (PBS)] was injected into animals 1 h prior to euthanasia. Anti-BrdU antibody (Dako; Cat. No. m744) was diluted 1:100 in blocking solution and incubated on the tissue sections for 1 h at 37°C or overnight at 4°C. Sections were washed three times in PBS, then incubated for 1 h with a secondary antibody diluted 1:200 in blocking solution. The avidin-biotin peroxidase detection system (Vector Laboratories) and the indicator substrate diaminobenzidine-H 2 O 2 were used to detect antibody complexes. Positive reactions result in the deposit of an insoluble brown precipitate.
Immunofluorescence
To detect collagen IV protein and laminin in situ, paraffinembedded sections were deparaffinized and rehydrated as stated previously. Tissue sections were predigested with Ficin (diluted 1:200 in PBS; Sigma; F-4125) for 30 min at 37°C, to unmask FIG. 1. Embryonic lens vasculature. The mouse embryonic day 15.5 (E15.5) ocular vasculature is depicted (A). The hyaloid artery enters the eye from the optic nerve head and extends branches through the vitreous (Barishak, 1992) . The hyaloid artery and all of its branches are collectively known as the hyaloid vascular system (Jack, 1972) . The first branches lie suspended in the vitreous between the surface of the retina and the lens and are known as the vasa hyaloidea propria (VHP). Subsequent branches extend toward the lens and run along its surface. These vessels are part of the lens vasculature known as the tunica vasculosa lentis (TVL). The TVL does not penetrate the lens but instead lies adjacent to the lens capsule. The anterior TVL is composed of a capillary plexus located in the pupillary membrane lying on the anterior surface of the lens. The ␣A-crystallin-VEGF minigene (B) consists of a 360-bp ␣A-crystallin promoter (black arrow) linked to a 596-bp human VEGF-A cDNA and SV40 early sequences, which provide intron and polyadenylation signals. The VEGF-A cDNA encodes the 165-amino-acid form of VEGF-A. The locations of the annealing sites for the primers Pr4 and SV40B which were used to identify transgenic mice are shown. To measure transgene expression by in situ hybridization, riboprobes corresponding to the SV40 sequences shown in the shaded region were used.
antigen. Sections were washed three times in PBS and then incubated in blocking solution (10% horse serum in PBS) for 1 h at room temperature. Sections were then incubated overnight at 4°C with either a rabbit anti-collagen IV antibody (Chemicon; AB765) diluted 1:100 in blocking solution or a rabbit anti-laminin antibody (Sigma; L9393) diluted 1:30 in blocking solution. Sections were washed three times in PBS and then incubated for 1 h at room temperature with a Cy3-labeled anti-rabbit secondary antibody (Jackson Laboratories; 111-165-144), diluted 1:200 in blocking solution (to detect collagen IV), or with an FITC-labeled anti-rabbit secondary antibody (Vector Laboratories; FI-1000), diluted 1:75. Smooth muscle actin was detected using an FITC-labeled antismooth muscle actin antibody (Sigma; F3777) diluted 1:500 in blocking solution overnight, then washed three times in PBS to remove unbound antibody. After the final wash, all slides were mounted in 50% glycerol-PBS containing 2 g/ml DAPI (Sigma) to label nuclei. Fluorescent complexes were detected using a Leica DMRB fluorescence microscope.
Scanning EM
To analyze the lens vasculature by scanning EM, tissue samples were fixed overnight in 3% glutaraldehyde in 0.1 M sodium cacodylate. After fixation samples were washed three times in 0.1 M cacodylate buffer. The sclera and retina were dissected from one side of the eye to reveal the vasculature on the surface of the lens. Tissues were postfixed in 1% osmium tetroxide in 0.1 M cacodylate buffer, washed three times in distilled water, and then dehydrated in a graded acetone series and subjected to three critical point drying runs. Samples were then mounted and sputter coated with tungsten and palladium. Coated samples were examined using a Joel JSM 6100 microscope.
RESULTS
Crystallin-VEGF-A Transgenic Mice
␣A-crystallin-VEGF-A minigene (Fig. 1B ) was used to generate three independent transgenic lines (OVE 702, 703, and 704). As the families had similar phenotypes, transgenic line OVE 703 was chosen for analysis. The phenotype of animals was analyzed at embryonic day 11.5 (E11.5), E12.5, E13.5, E14.5, E15.5, E18.5, day of birth (PO), postnatal day 5 (P5), P7, P10, P14, and P21. At least two animals were analyzed for each age. This age range was chosen to observe the effects of VEGF-A on development of the embryonic lens vasculature and on subsequent TVL regression.
Transgenic VEGF-A Enhances Early Lens Vascularization
We observed very little difference between normal and transgenic eyes at E12.5, with only a modest increase in the number of cells on the posterior and lateral sides of the lens in transgenic eyes (Fig. 2B ) compared to normal eyes ( Fig.  2A) . In nontransgenic eyes, these cells are angioblasts and endothelial cells, which will give rise to the hyaloid vascular system that is well established by E14 (Fig. 2C) . In transgenic animals, significantly more of these cells accumulate, so that by E14.5, they had formed into a dense cluster of cells on the lens surface (asterisk, Fig. 2D ). In the vitreous of transgenic eyes, hyaloid artery branching was more complex than in normal eyes; however, the vessels did not form a distinct VHP (Fig. 2D ). While excess cells accumulated around the lens, no cells were observed to migrate into the lens.
VEGF Expression Causes an Accumulation of Angioblasts and Endothelial Cells
Expression of the VEGF-A transgene was analyzed by in situ hybridization to confirm lens-specific expression. Transgene expression was found only in the lens fiber cells and was detected as early as E11.5 (Fig. 3A) . Transgene expression was increased in the fiber cells of E12.5 lenses (not shown) and was expressed at the highest level by E15.5 (Fig. 3B ). Transgene expression was also observed at E18 (not shown) and during postnatal development at ages P5 ( Fig. 3C ) and P14 (Fig. 3D ).
Based on their location, morphology, and accumulation in response to VEGF-A expression, the extra cells surrounding the transgenic lenses were expected to be a mixed population of angioblasts and endothelial cells. To confirm this prediction, the expression patterns of the high-affinity VEGF-A receptors Flk-1 and Flt-1, and the tyrosine kinase receptor Tie2 (or Tek), were analyzed by in situ hybridization (Fig. 4) . Flt-1 is expressed by nonvascular endothelial cells including monocytes (Breier et al., 1995; Clauss et al., 1996) ; however, no monocytes were identified in the cell mass using the F480 antibody (not shown). Flk-1 has been shown to be expressed in the retina (Yang et al., 1996) , and Tie2 is expressed in lens epithelial cells (unpublished observations). However, only angioblasts and vascular endothelial cells express all three markers. Flk-1 was expressed by most of the cells surrounding the transgenic E12.5 lens (Fig. 4B) , and the number of cells expressing Flk-1 was dramatically increased in transgenic eyes, by E15.5. In the E15.5 transgenic eye most of the accumulating cells also expressed high levels of Flt-1 and expressed Tie2. A majority of the cells that accumulate around transgenic lenses express all three receptors, identifying them as either angioblasts or endothelial cells. There were a few cells that did not express Flk-1 (Fig. 4D ) and a few cells that did not express Flt-1 (Fig. 4E) . Cells that did not express Flk-1 (Figs. 4A and 4C) or Flt-1 (not shown) were also observed in nontransgenic animals. These cells may represent mesenchymal cells which can give rise to pericytes. However, they did not express the pericyte marker smooth muscle actin (not shown).
VEGF-A Induces Localized Vascular Cell Hyperplasia
The incorporation of BrdU into the DNA of replicating cells was analyzed to determine if transgenic expression of VEGF-A was affecting cell proliferation. In both nontransgenic and transgenic E12.5 eyes, many of the cells around the lens stained positive for BrdU incorporation, indicating a high rate of proliferation (arrows, Figs. 5A and 5B). BrdU-positive cells in serial sections demonstrated similar proliferation rates in E12.5 transgenic and nontransgenic eyes, with 39 and 38% of the cells around the lens in S phase at the time of sacrifice (Table 1 ). In the nontransgenic E15.5 eye (Fig. 5C ), the percentage of BrdU-positive cells decreased to 22% (Table 1) , while in transgenic E15.5 eyes the rate of proliferation remained high with 31% of the cells positive for BrdU (Fig. 5D and Table 1 ). The proliferation of hyaloid cells in the nontransgenic E18 eye decreased sharply to 9%, and no positive cells were observed in the TVL of nontransgenic newborn mice (Table 1) . In contrast, neonatal and postnatal transgenic animals continued to have elevated cell proliferation rates, although the rates decreased with age (Table 1 ). The peak of angioblast and endothelial cell proliferation was coincident with the peak of transgene expression at E15.5.
FIG. 2.
Transgenic VEGF-A enhances intraocular vascularization. In nontransgenic E12.5 eyes (ntg) vascular cells accumulate between the lens and the retina (A). The abundance of these cells increased slightly in the transgenic (tg) E12.5 eyes (B). The lens vascular system with a clearly identifiable TVL on the surface of the lens is seen in nontransgenic E14.5 eyes (arrow, C). In age-matched transgenic eyes, a dense cluster of cells accumulated on the surface of the lens (D). The majority of these cells were not organized into blood vessels (asterisk, D). The vascular branching from the hyaloid artery (h) was more extensive in transgenic eyes (C and D). Scale bars, 100 m. Abbreviations: l, lens; h, hyaloid artery; od, optic disc.
Angiogenic Remodeling in the Postnatal Vascular Bed
To study the fate of the angioblasts and endothelial cells, we analyzed perinatal and postnatal eyes by histology. On the surface of the E18 transgenic lens, the vascular bed was composed of several layers of blood vessels (Figs. 6B and  6C ). In addition, the vasa hyaloidea propria (VHP) was less extensive and was disorganized compared to normal (Fig.  6A) . In transgenic P0 eyes (Fig. 6E) , the VHP was still poorly organized compared to that of nontransgenic eyes (Figs. 6D  and 6E ). The vascular bed in transgenic P0 eyes (Fig. 6F) consisted of single layers of abnormal vessels with large dilated lumen-like structures with unusually thin walls (arrowheads, Fig. 6F ). The conversion of small multilayered vessels to single layered and dilated vessels suggested extensive vascular remodeling. Numerous pillars of endothelial cells and matrix (Fig. 7A) were observed in the P0 vascular bed, further suggesting angiogenic remodeling. Most of the cells in the vascular bed were positive for the VEGF-A receptors Flt-1 and Flk-1 by in situ hybridization (not shown). In P5 transgenic animals, the number and size of blood vessels were visibly reduced. Most of the space within the vascular bed was filled with cells (Fig. 7B) . A few remaining channels containing red blood cells were evident; however, the majority of the cells were not obviously integrated into organized blood vessels (Fig. 7B) . In some regions of the P14 vascular bed, there was a significant reduction in the number of cells, with the majority of the remaining cells organized into blood vessels (Fig. 7C) . However, in other regions the vascular bed remained disorganized (Fig. 7D) . In the P21 transgenic eyes, well-defined blood vessels of various sizes were evident (Figs. 7E and 7F) . Some of the vessels had a high density of endothelial cells and thick basement membranes (Fig. 7E) . Pericytes expressing smooth muscle actin were associated with many of the   FIG. 3 . Lens-specific expression of transgenic VEGF-A. In situ hybridization using an 35 S-labeled riboprobe specific to the SV40 sequences in the transgene RNA was used to demonstrate lens-specific transgene expression at E11.5 (A), E15.5 (B), P5 (C), and P14 (D). Scale bars indicate 50 m (A and B) and 500 m (C and D).
blood vessels in the P21 transgenic eye (arrowheads, Figs. 7E and 7F) .
To further characterize the postnatal vascular remodeling, P5, P14, and P21 eyes were analyzed by scanning electron microscopy. At P5 the surface of the transgenic vascular bed had a uniform covering of matrix (vb, Fig. 8B ). Some of the surface material was removed during dissection to observe the structure underneath (Fig. 8B) . Analysis of this region suggests that the vascular cells have formed a spongiform vascular bed lying on the surface of the lens. The vascular bed appears to have channels which would be capable of transporting blood (ϩ, Fig. 8B ). In some regions on the surface of the P14 transgenic lens there were distinct blood vessels (Figs. 8D and 8E ). However, in other areas the vascular bed was similar to that in P5 eyes (not shown). By P14 the vessel density of the normal TVL was dramatically reduced (Fig. 8C) . The blood vessels were collapsed and discontinuous with obvious gaps between terminals (arrows, Fig. 8C ). In addition, numerous tissue-specific macrophages (hyalocytes) were evident (large arrowheads, Fig.  8C ), which are thought to play a role in the regression of the hyaloid vascular system (HVS) (Lang et al., 1993 (Lang et al., , 1994 .
FIG. 4. Expression of angioblast and endothelial cell markers. Expression of the VEGF receptors Flk-1 (A-D)
and Flt-1 (E) and the tyrosine kinase receptor Tie-2 (F) was assayed by in situ hybridization using 35 S-labeled riboprobes. The red color indicates hybridization to the indicated probe. A and C are images of nontransgenic control eyes at E12.5 and E15.5, respectively. B is an image of a transgenic eye at E12.5, and D-F are images of transgenic eyes at E15.5. Scale bars, 100 m. Abbreviations: l, lens; r, retina.
Numerous macrophage-like cells were also present on the surface of the transgenic P14 lens (round cells on top of the vessels, Figs. 8D and 8E ). By P21 in the normal eye, the HVS has almost completely regressed (not shown). In the P21 transgenic eye, the entire lens surface was covered by blood vessels of various sizes (Fig. 8F) . Some of the larger vessels appear to branch into smaller vessels (arrow, Fig. 8F ). Most of the vessels were oriented in a posterior to anterior direction along the lens surface.
Developmental Changes in Basement Membrane Synthesis
Localization of collagen IV and laminin was used to determine if cells around the lens were maintaining an appropriate basement membrane. The high-density cell mass in E15.5 transgenic eyes (asterisk, Fig. 9A ) had very low levels of collagen IV. These same cells were positive for laminin (Fig. 9B) . However, at higher magnification (not shown) it was apparent that laminin was localized within the cytoplasm of the cells rather than in an organized basement membrane. At later ages collagen IV and laminin had similar localizations. Both collagen IV (Fig. 9C) and laminin (not shown) were uniformly distributed throughout the vascular bed around the E18.5 transgenic lens and were predominately localized in the basement membranes of the multilayered vessels (v, Fig. 9C ). In P0 transgenic eyes, both proteins were found in the outer fibrous layer of the vascular bed and in the ribbons of matrix that extended into the enlarged vessels (arrow, Fig. 9D ). By P5, almost all of the cells in the vascular bed were positive for collagen IV (Fig.  9E) . The distinct blood vessels around the lenses of P14 (not shown) and P21 (Fig. 9F ) transgenic eyes demonstrated intense laminin (not shown) and collagen IV staining in their basement membranes.
Environmental Changes of the Lens Vascular Bed
In postnatal transgenic lenses, the fiber cells degenerated (manuscript in preparation), and fluid accumulated in the center of the lens (Fig. 10) . By P5 the lens is well separated   FIG. 6 . Neonatal vascular organization. Nontransgenic (ntg) E18 eye (A) has a well-developed TVL, lying on the surface of the lens (l), and the VHP (arrow) is near the surface of the developing retina. The VHP in the transgenic E18 eye (B and C) was much less organized in the vitreous (arrow, B). Several layers of blood vessels (v, C) were apparent on the surface of the E18 lens. Note the large vessel in the vitreous (white arrow, C). The transgenic P0 eye had a remnant of the VHP (arrow, E), and a single layer of enlarged vessels (arrowheads, F) on the surface of the P0 vascular bed. The curved arrows in C and E indicate the boundary between the lens and the vascular bed.
from the retina (Fig. 10A) , but by P14, some areas of the lens surface make contact with the retinal surface (arrows, Fig.  10B ). Improved blood vessel differentiation first occurred in these areas of contact. By P21 the lenses had expanded to fill the space within the eye, so that most of the lens vascular bed became juxtaposed to the inner surface of the retina (Fig. 10B) . The maturation of the lens vascular bed appeared to be enhanced at this age, perhaps as a consequence of interactions with proteins from the adjacent retina and its vasculature.
FIG. 7. Histology of vascular organization changes.
To analyze the cellular organization in the remodeling vascular bed, 5-m sections of transgenic eyes were stained with hematoxylin and eosin. In each image, the vascular bed is below the lens and the arrows mark the boundary. Note the large irregularly shaped blood vessels in the P0 transgenic vascular bed (A). Most of the vessels were separated by single endothelial cell pillars. The P5 transgenic lens (B) was surrounded by a dense bed of cells, most of which expressed Flk-1 (not shown). Note the red blood cells in small channels within the cellular bed. The vascular bed in some regions of the P14 transgenic lens was composed of distinct but irregularly shaped blood vessels (C). Around other regions of the P14 lens, the vascular bed retained the spongiform structure found in the P5 vascular bed (D). In P21 transgenic eyes (E and F), well-formed blood vessels were present and consisted of endothelial cells, a basement membrane, and pericytes (arrowhead, E), which were identified by immunofluorescence detection of smooth muscle actin (arrowhead, F). Scale bar, 10 m.
DISCUSSION
We have generated three independent lines of transgenic mice that express human VEGF-A 165 specifically in the lens. Expression was observed as early as E11.5 with continued expression through P21 (expression at later times was not determined). Transgenic synthesis of VEGF-A resulted in the formation of a vascular bed around the lens, which underwent dynamic change as the animals aged (summarized in Fig. 11 ). The nature of the lens vascular bed suggests that VEGF-A participates in vasculogenesis as a potent mediator of angioblast migration and proliferation and also participates in angiogenesis as a mediator of endothelial cell proliferation and reorganization. The results also demonstrate that blood vessel development requires a balance between VEGF-A and coordinating signals. The arrow in C indicates a vessel that was in the process of degeneration. Numerous macrophages (hyalocytes) can be seen on the surface of the nontransgenic lens (arrowheads, C). The vascular bed in some regions of the lens in P14 transgenic (tg) eyes had resolved into distinct blood vessels (arrows, D and E). However, most were dilated and irregular. In E, the cut ends of blood vessels can be seen (arrows). By P21 prominent vessel structures are seen on the entire lens surface (F). All of the vessels were aligned posterior to anterior (anterior is up) and exhibit some branching (arrow, F). Scale bars, 100 m.
Interestingly, we did not observe vascular tissue within the lens itself, despite the fact that the VEGF-A concentration should be highest within this tissue. This suggests that the environment within the lens is inhibitory for vascular invasion. The mechanism for this inhibition is not known at this time.
FIG. 9.
Basement membrane synthesis. Immunolocalization of collagen IV (red) and laminin (green fluorescence) is shown. These proteins are major components of blood vessel basement membranes and were analyzed to determine the extent of vascular organization. The high-density cell mass in E15.5 transgenic eyes (asterisk, A) had very low levels of collagen IV compared to the blood vessels in the vitreous. Cells in the cell mass nearest the E15.5 lens (B) had pericytoplasmic laminin staining, suggesting that these cells had not yet differentiated sufficiently to acquire a polarized characteristic. Collagen IV and laminin antibodies gave similar patterns of staining at all other ages; therefore, only collagen IV is shown for subsequent ages. Collagen IV was localized to vascular basement membranes in E18.5 eyes (C). In P0 transgenic eyes, collagen IV was found in the outer fibrous layer of the vascular bed, with some protein detected as ribbons extending into the dilated vessels (arrow, D). By P5 most of the cells were positive for collagen IV; however, the protein was not distributed to well-defined basement membranes (E). The distinct blood vessels around the lenses of P14 (not shown) and P21 transgenic eyes (F) demonstrated intense collagen IV staining localized to basement membranes. The blue and red lines mark the boundary between the lens (l) and the vascular bed. Blood vessels in the retina (r) and the inner limiting membrane of the retina were also positive.
VEGF-A Expression Enhances Vasculogenesis but Is Not Sufficient to Direct Blood Vessel Organization
An impressive mass of Flt-1-and Flk-1-positive cells accumulates around the lenses of E15.5 transgenic animals, and excessive microvessels form in the vitreous. The vascular bed at E15.5 is composed of mixed cell populations, most of which are angioblasts or endothelial cells based on Flk-1, Flt-1, and Tie2 expression. The distinction between angioblasts and endothelial cells currently is not clearly defined by molecular markers. Therefore, we must rely on morphological classification to distinguish between these related cell types. The dense cluster of cells nearest to the E15.5 transgenic lens (Fig. 2D ) lack distinct blood vessels with organized basement membranes (Figs. 9A and 9B) , suggesting that these cells are angioblasts. Cells farther away from the E15.5 lens are positive for collagen IV and laminin and are forming blood vessels, suggesting that these cells have differentiated into endothelial cells.
During normal vasculogenesis in the embryo, the expression pattern of VEGF-A is consistent with the hypothesis that it provides a chemoattractant and mitogenic signal to angioblasts (Breier et al., 1992 (Breier et al., , 1995 Dumont et al., 1995; Koch et al., 1994) . In the VEGF-A transgenic mice we observed evidence for both roles. Shortly after the onset of transgene expression, we observed a small increase in the number of angioblasts around the lens that cannot be accounted for by increased proliferation rates. This observation suggests that VEGF-A is a chemoattractant for vascular endothelial progenitors. The role of VEGF-A as a chemoattractant for angioblasts has recently been demonstrated in Xenopus development (Cleaver et al., 1998) . If   FIG. 10 . Well-formed blood vessels are coincident with contact of the retina. Hematoxylin-and eosin-stained sections showing changes in the spatial relationship between the lens (l) and the retina (r) in transgenic P5 (A), P14 (B), and P21 (C) lenses. In P5 transgenic eyes (A), the lens vascular bed is separated from the retina by a substantial vitreous space. In P14 eyes (B), the lens vascular bed begins to make contact with the retina (arrows). Blood vessels are first apparent at these sites. In P21 eyes (C), the retina is often detached from the RPE and is attached to the lens vascular bed. Scale bar, 500 m. VEGF-A were a guidance signal for angioblast migration, then the absence of a chemoattractant signal could explain the abnormal distribution of endothelial cells observed in embryos that lack VEGF-A (Carmeliet et al., 1996) . By E15.5, we observed excessive accumulation of angioblasts and endothelial cells, which can be attributed to a persistent high rate of proliferation. This demonstrates that VEGF-A is a potent mitogen for angioblasts as well as endothelial cells. The role of VEGF-A as a mitogen for angioblasts suggests that the reduction of endothelial cells seen in VEGF-A null mice could be the result of impaired proliferation of endothelial stem cells as well as endothelial cells (Ferrara et al., 1996; Carmeliet et al., 1996) .
Despite the accumulation of angioblasts around the lens, the cells do not efficiently organize into mature blood vessels, suggesting that VEGF-A stimulation alone is not sufficient for blood vessel development. It is unlikely that VEGF-A-induced proliferation directly inhibits organization of vessels, since the nontransgenic E15.5 HVS had a high BrdU index (22%) and well-defined blood vessels (Fig.  2) . A more likely model predicts that the normal HVS is a rapidly growing and organized vascular network because there is a balance between the VEGF-A proliferation signal and the collaborating organizational signals. Near the lens in the transgenic eye, where the VEGF-A concentration would be highest, this balance would be shifted dramatically toward proliferation, leading to the accumulation of proliferating cells that do not form blood vessels. At a distance from the transgenic lens, VEGF-A levels would be lower and the balance in signals would be more favorable for vessel organization, allowing the overgrowth of blood vessels seen at a distance from the lens in the E15 eye (Fig.  2D ).
VEGF-A Stimulates Angiogenic Remodeling in Postnatal Eyes
During the late embryonic and early postnatal development (E18 -P14), the vascular bed around the transgenic lenses appears to be undergoing constant remodeling. The distinct blood vessels observed in the vascular beds of E18 and P0 animals were positive for collagen IV and laminin, suggesting that the angioblasts had differentiated into endothelial cells. The E18 transgenic vasculature consisted of several layers of blood vessels lying on the lens surface. The histology suggests that the multilayered vessels were not stable, and by P0, they had fused together to form thinwalled and dilated vessels. VEGF-A-stimulated fusion of small vessels to form large vascular sacs was also observed when exogenous VEGF-A was applied to quail embryos during the time of normal vasculogenesis (Drake et al., 1995) . In the eyes of transgenic mice the dilated vessels also were not stable and became filled-in with proliferating endothelial cells by P5, so that the abnormal vessels were restricted to small channels percolating through a dense vascular bed. These early postnatal changes are evidence that VEGF-A alone does not promote stable vascular structures.
Excess VEGF-A expression in the developing limb buds of chicks has been shown to induce localized hypervascularization (Flamme et al., 1995b) . In addition, VEGF-A has also been used as a therapeutic agent to promote collateral vascularization around blocked arteries in the brain, in myocardium, and around ischemic vessels in limbs (Baumgartner et al., 1998; Hayashi et al., 1998; Rivard et al., 1998) . In all of these environments VEGF-A alone appears sufficient to promote blood vessel development. The apparent ability of VEGF-A to stimulate the growth and organization of blood vessels in some tissues, but not around the neonatal lens, suggests that organization of blood vessels is environment dependent. Permissive or nonpermissive environments may be determined by the abundance of organizational signals relative to the VEGF-A proliferation signal. In permissive environments, VEGF-A can stimulate proliferation of endothelial cells, which organize into blood vessels due to sufficient levels of collaborating organizational signals. In a nonpermissive environment, the collaborating signals are not at sufficient levels to promote the development of organized vessels, resulting in endothelial cell proliferation and vascular remodeling. An obvious interpretation for the inability of VEGF-A alone to form vessels in neonatal transgenic eyes is that organizational signals may be significantly underrepresented relative to the VEGF-A signal. Alternatively, the lens may express factors that inhibit vascular development on its surface. However, this seems unlikely since the normal lens is vascularized by the TVL at this age, and well-organized blood vessels were observed in P21 transgenic mice.
The correlation between blood vessel differentiation and proximity to the retina suggests that the mechanism of enhanced maturation is more complicated than a simple reduction in VEGF-A levels. It is more likely that the retina may be the source for vascular organizational signals. The biological response of endothelial cells to VEGF-A has been suggested to depend on the presence of other signals produced by surrounding tissues (Suri et al., 1996 (Suri et al., , 1998 Maisonpierre et al., 1997; Hanahan, 1997) . During the first and second postnatal weeks, the retinal vasculature is developing; therefore, the retina must be sending all necessary signals for growth and organization of blood vessels. As the lens vascular bed approaches the retina, the localized concentration of these signals would increase. The poor organization of blood vessels in early postnatal transgenic mice suggests that the levels of the collaborating signals are not sufficient to balance the excess VEGF-A, resulting in hyperproliferation and poor vascular organization. With the combination of decreasing VEGF-A levels with age and increasing levels of collaborating signals as the vascular bed nears the retina, the balance is shifted to favor blood vessel differentiation. Indeed, evidence that the retina can promote blood vessel differentiation has been demonstrated by the organization of ectopic vessels in transgenic mice expressing VEGF-A in photoreceptors (Tobe et al., 1998; Okamoto et al., 1997) . In these mice, there was organization of vessels without excessive cellular accumulation. Alternatively, it is possible that poor blood vessel development in early postnatal VEGF-A transgenic mice is the result of an insufficient population of mesenchymal cells and pericytes to interact with the overabundance of vascular endothelial cells. Perturbations in endothelialmesenchymal cell ratios have also been described as a mechanism to explain the vascular defects in mice that have a null mutation in the VEGF-A receptor Flt-1 (Fong et al., 1999) . A possible consequence of this cellular imbalance may be an inadequate supply of essential blood vessel differentiation signals like angiopoietin-1 (Suri et al., 1996 (Suri et al., , 1998 Sato et al., 1995) or the activation of TGF␤-1, which is also essential for blood vessel maturation (Dickson et al., 1995) . The late development of blood vessels when the lens is in proximity to the retina may be the result of recruiting retinal astrocytes or pericytes from the retinal vasculature.
The VEGF-A-transgenic mice provide a useful in vivo model system in which to study the combinatorial role of molecular signals which coordinate vascular development. By expressing coactivators of vascularization along with VEGF-A in transgenic lenses we should be able to study the effects of these factors on vascular cell proliferation, organization, or cell death in vivo.
